|
|
|
Insider
Information: |
Herman Melanie J |
Relationship: |
Director of Accounting |
City: |
La Jolla |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
3,454 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$246,685 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
3,454 |
|
|
Total
Value |
$246,685 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ligand Pharmaceuticals Inc |
LGND |
Director of Accounting |
2016-06-30 |
3,454 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LGND |
Ligand Pharmaceuticals In... |
Director of Accounting |
|
2016-06-30 |
4 |
A |
$87.10 |
$13,675 |
D/D |
157 |
3,454 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director of Accounting |
|
2016-05-18 |
4 |
S |
$120.50 |
$40,247 |
D/D |
(334) |
3,297 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director of Accounting |
|
2016-02-15 |
4 |
D |
$85.97 |
$13,755 |
D/D |
(160) |
3,631 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director of Accounting |
|
2016-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
500 |
3,791 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director of Accounting |
|
2015-12-31 |
4 |
A |
$82.53 |
$11,554 |
D/D |
140 |
3,291 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director of Accounting |
|
2015-11-11 |
4 |
S |
$101.00 |
$779,619 |
D/D |
(7,719) |
3,151 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director of Accounting |
|
2015-11-11 |
4 |
OE |
$11.15 |
$365,034 |
D/D |
7,719 |
10,870 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Interim CFO |
|
2015-06-30 |
4 |
A |
$45.67 |
$7,536 |
D/D |
165 |
3,151 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Interim CFO |
|
2015-06-10 |
4 |
S |
$93.50 |
$385,688 |
D/D |
(4,125) |
2,986 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Interim CFO |
|
2015-06-10 |
4 |
OE |
$11.91 |
$156,885 |
D/D |
4,125 |
7,111 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director of Accounting |
|
2015-03-02 |
4 |
S |
$60.69 |
$32,469 |
D/D |
(535) |
2,986 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director of Accounting |
|
2015-02-19 |
4 |
S |
$57.84 |
$29,498 |
D/D |
(510) |
3,521 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director of Accounting |
|
2015-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,200 |
4,031 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director of Accounting |
|
2014-12-31 |
4/A |
A |
$45.23 |
$4,659 |
D/D |
103 |
2,831 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director of Accounting |
|
2014-12-31 |
4 |
B |
$45.23 |
$4,659 |
D/D |
103 |
2,831 |
2.66 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director of Accounting |
|
2014-06-30 |
4 |
B |
$43.79 |
$4,292 |
D/D |
98 |
2,728 |
2.66 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director of Accounting |
|
2014-06-09 |
4 |
S |
$69.68 |
$76,648 |
D/D |
(1,100) |
2,630 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director of Accounting |
|
2014-06-09 |
4 |
OE |
$11.91 |
$13,741 |
D/D |
1,100 |
2,880 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director of AccountingOfficer |
|
2014-04-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,630 |
|
- |
|
19 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|